Article Type
Original Research
Published
This article assesses the effectiveness and tolerability profile of vericiguat in clinical practice in patients with heart failure with reduced ejection fraction and an implantable cardioverter-defibrillator, with an emphasis on the emergence of ventricular arrhythmias.
